Related references
Note: Only part of the references are listed.A tripartite mechanism catalyzes Mad2-Cdc20 assembly at unattached kinetochores
Pablo Lara-Gonzalez et al.
SCIENCE (2021)
Targeting Hedgehog signalling in CD133-positive hepatocellular carcinoma: improving Lenvatinib therapeutic efficiency
Qingqing Hu et al.
MEDICAL ONCOLOGY (2021)
ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway
Nuozhou Wang et al.
CANCER LETTERS (2020)
A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycytnemia
Jiong Yu et al.
AGING-US (2020)
CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma
Ling Li et al.
CELL CYCLE (2020)
Functioning mechanisms of Shugoshin-1 in centromeric cohesion during mitosis
Qian Zhang et al.
KINETOCHORES AND CHROMOSOME SEGREGATION (2020)
A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma
Chunmei Guo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Securin-independent regulation of separase by checkpoint-induced shugoshin-MAD2
Susanne Hellmuth et al.
NATURE (2020)
Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma
Yalei Zhao et al.
CELL PROLIFERATION (2020)
Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma
Long-Hui Zhang et al.
Hepatobiliary & Pancreatic Diseases International (2020)
Pervasive chromosomal instability and karyotype order in tumour evolution
Thomas B. K. Watkins et al.
NATURE (2020)
Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update
Masatoshi Kudo
LIVER CANCER (2020)
Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data
Xi Tian et al.
ONCOIMMUNOLOGY (2020)
Targeting MAD2 modulates stemness and in human Gastric Cancer cell lines
Natalia Pajuelo-Lozano et al.
THERANOSTICS (2020)
The Ectopic Expression of Meiosis Regulatory Genes in Cutaneous T-Cell Lymphomas (CTCL)
Jennifer Gantchev et al.
FRONTIERS IN ONCOLOGY (2019)
Targeting transcription factors in cancer - from undruggable to reality
John H. Bushweller
NATURE REVIEWS CANCER (2019)
ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis
Fuliang Qian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
Samra Turajlic et al.
CELL (2018)
Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma
Weijian Sun et al.
LABORATORY INVESTIGATION (2018)
Targeting ZBP-89 for the treatment of hepatocellular carcinoma
Nuozhou Wang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Mutations of SGO2 and CLDN14 collectively cause coincidental Perrault syndrome
R. Faridi et al.
CLINICAL GENETICS (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ETV6 in hematopoiesis and leukemia predisposition
Hanno Hock et al.
SEMINARS IN HEMATOLOGY (2017)
The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses
Tara Byrne et al.
ONCOTARGET (2017)
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles
Ana Vanessa Nascimento et al.
ACTA BIOMATERIALIA (2017)
Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
M. V. Novikova et al.
BIOCHEMISTRY-MOSCOW (2017)
MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1
Yuanhang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice
Chinthalapally V. Rao et al.
CANCER RESEARCH (2016)
Shugoshin forms a specialized chromatin domain at subtelomeres that regulates transcription and replication timing
Sanki Tashiro et al.
NATURE COMMUNICATIONS (2016)
Targeting Zfp148 activates p53 and reduces tumor initiation in the gut
Anna Nilton et al.
ONCOTARGET (2016)
The multifaceted roles of the HORMA domain in cellular signaling
Scott C. Rosenberg et al.
JOURNAL OF CELL BIOLOGY (2015)
被撤回的出版物: The inner centromere-shugoshin network prevents chromosomal instability (Retracted article. See vol. 357, pg. 981, 2017)
Yuji Tanno et al.
SCIENCE (2015)
Sgo1 is a potential therapeutic target for hepatocellular carcinoma
Lyu-Han Wang et al.
ONCOTARGET (2015)
Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
Roland F. Schwarz et al.
PLOS MEDICINE (2015)
Shugoshins: Tension-Sensitive Pericentromeric Adaptors Safeguarding Chromosome Segregation
Adele L. Marston
MOLECULAR AND CELLULAR BIOLOGY (2015)
Transcriptional Regulation and Its Misregulation in Disease
Tong Ihn Lee et al.
CELL (2013)
Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
Teresa Davoli et al.
CELL (2013)
Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis Implications for the treatment of human liver cancer
Chunmei Wang et al.
CELL CYCLE (2013)
A novel treatment strategy targeting shugoshin 1 in hematological malignancies
Jing Yang et al.
LEUKEMIA RESEARCH (2013)
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack et al.
NATURE GENETICS (2013)
Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes
Yafang Wang et al.
TUMOR BIOLOGY (2013)
SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers
Shun Matsuura et al.
SCIENTIFIC REPORTS (2013)
Cancer chromosomal instability: therapeutic and diagnostic challenges
Nicholas McGranahan et al.
EMBO REPORTS (2012)
Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma
Chris Z. Y. Zhang et al.
HISTOPATHOLOGY (2012)
Shugoshins: from protectors of cohesion to versatile adaptors at the centromere
Cristina Gutierrez-Caballero et al.
TRENDS IN GENETICS (2012)
Sister Chromatid Cohesion Control and Aneuploidy
J. L. Barbero
CYTOGENETIC AND GENOME RESEARCH (2011)
Shugoshin is a Mad1/Cdc20-like interactor of Mad2
Michael Orth et al.
EMBO JOURNAL (2011)
Knockdown of Mad2 induces osteosarcoma cell apoptosis-involved Rad21 cleavage
Ling Yu et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2011)
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
David A. Solomon et al.
SCIENCE (2011)
The Bcl-xL Inhibitor, ABT-737, Efficiently Induces Apoptosis and Suppresses Growth of Hepatoma Cells in Combination with Sorafenib
Hayato Hikita et al.
HEPATOLOGY (2010)
Shugoshin-2 is essential for the completion of meiosis but not for mitotic cell division in mice
Elena Llano et al.
GENES & DEVELOPMENT (2008)
Mad2 overexpression promotes aneuploidy and tumorigenesis in mice
Rocio Sotillo et al.
CANCER CELL (2007)
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
Scott L. Carter et al.
NATURE GENETICS (2006)
Shugoshin collaborates with protein phosphatase 2A to protect cohesin
TS Kitajima et al.
NATURE (2006)
Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I
CG Riedel et al.
NATURE (2006)
Shugoshin: guardian spirit at the centromere
Y Watanabe
CURRENT OPINION IN CELL BIOLOGY (2005)
Shugoshin protects cohesin complexes at centromeres
Y Watanabe et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2005)
The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint
A De Antoni et al.
CURRENT BIOLOGY (2005)
The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis
TS Kitajima et al.
NATURE (2004)
ZBP-89-induced apoptosis is p53-independent and requires JNK
L Bai et al.
CELL DEATH AND DIFFERENTIATION (2004)
ZBP-89 promotes growth arrest through stabilization of p53
LG Bai et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)